/index.php?option=com_iwpfile&file=/dir_01/he2002_2658.pdf


er

The National Organization of Women and Planned Parenthood issued separate statements opposing the possible appointment of W. David Hager to the FDA Reproductive Health Drugs Advisory Committee. Additionally, Sen. Barbara Boxer (D-CA) sent a letter to President Bush expressing concern over the possible appointment due to Hager's writings about the role of religion in healing. The Family Research Council (FRC) responded to the opposition, highlighting Hager's credentials and current work on federal health advisory committees.



FOR IMMEDIATE RELEASE

October 17, 2002

Media Inquiries:

301-436-2335

P02-42

Consumer Inquiries:

888-INFO-FDA



/index.php?option=com_iwpfile&file=/dir_01/he2002_2654.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2655.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2653.pdf


om Attending The Confirmation Hearing For Comissioner Nominee Mark McClellan

Crawford: FDAers Shouldn't Go to McClellan Hearing

10/04/2002



/index.php?option=com_iwpfile&file=/dir_01/he2002_2652.pdf


"I am pleased that the committee took the lead on the issue by providing a forum for discussion between both sides of the debate," House Energy and Commerce Committee Chair Billy Tauzin (R-LA) says in an Oct. 17 statement.



/index.php?option=com_iwpfile&file=/dir_01/he2002_2649.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.